Ruge, T., Larsson, A., Lipcsey, M., Tydén, J., Johansson, J., & Eriksson, M. (2021). A Comparison between Endostatin and Conventional Biomarkers on 30-Day Mortality and Renal Replacement Therapy in Unselected Intensive Care Patients. MDPI AG.
Cita Chicago Style (17a ed.)Ruge, Toralph, Anders Larsson, Miklós Lipcsey, Jonas Tydén, Joakim Johansson, y Mats Eriksson. A Comparison Between Endostatin and Conventional Biomarkers on 30-Day Mortality and Renal Replacement Therapy in Unselected Intensive Care Patients. MDPI AG, 2021.
Cita MLA (8a ed.)Ruge, Toralph, et al. A Comparison Between Endostatin and Conventional Biomarkers on 30-Day Mortality and Renal Replacement Therapy in Unselected Intensive Care Patients. MDPI AG, 2021.
Precaución: Estas citas no son 100% exactas.